连云港市2012—2021年出生队列儿童EV 71型疫苗接种情况分析

doi:10.12183/j.scjpm.2023.0981

摘要/Abstract

摘要： 目的分析连云港市2012—2021年出生队列儿童EV 71型疫苗接种现状,为制定疫苗接种策略和科学防控手足口病提供依据。方法利用江苏省预防接种综合服务管理信息系统建立自2017年EV 71型疫苗在连云港市开始接种以来适龄儿童的出生队列,分析出生队列儿童EV 71型疫苗接种情况。结果连云港市2012—2021年出生队列儿童500 016名。截至2021年12月31日,连云港市2012—2021年出生队列儿童接种首剂EV 71型疫苗71 715人,接种率为14.34%;完成全程接种60 915人,全程接种率为12.18%。2012—2017年出生队列儿童EV 71型疫苗接种率和全程接种率在2018年度最高,2018—2020年出生队列儿童EV 71型疫苗接种率和全程接种率在出生后第2年最高。接种首剂EV 71型疫苗年龄中位数为14月龄（IQR为15月龄）。流动儿童、市区儿童、女童的EV 71型疫苗接种率及全程接种率均较高（均P<0.01）。结论连云港市2012—2021年出生队列儿童EV 71型疫苗接种率有所上升,但总体水平仍然较低。免疫起始月龄较晚,居住属性、居住地区、性别不同的儿童EV 71型疫苗接种情况存在一定差异,需针对性开展工作。

关键词: 出生队列, EV 71疫苗, 预防接种, 接种率

Abstract: Objective To analyze the EV 71 vaccination status in the 2012-2021 birth cohort in Lianyungang City and provide a basis for formulating vaccination strategies and scientific prevention and control of hand-foot-mouth disease. Methods Using the Jiangsu Vaccination Provincial Management Information System, we established the birth cohort of age-eligible children since EV 71 vaccination began in 2017 in Lianyungang City, and analyzed the EV 71 vaccination status of these children. Results A total of 500 016 children managed in the 2012-2021 birth cohort in Lianyungang City. As of December 31, 2021, 71 715 children in the 2012-2021 birth cohort in Lianyungang City had received the first dose of EV 71 vaccine, with a vaccination rate of 14.34%; 60 915 children were whole-course vaccinated, with a whole-course vaccination rate of 12.18%. The vaccination rate and whole-course vaccination rate of EV 71 vaccine were highest in 2018 for children in the 2012-2021 birth cohort, and the highest in the second year of life for children in the 2018-2020 birth cohort. The median age for the first dose of vaccination was 14 months （interquartile range 15 months）.Migrant children, urban children, and girls had higher EV 71 vaccination rate and whole-course vaccination rate （all P<0.01）. Conclusions The EV 71 vaccination rate of children in the 2012-2021 birth cohort in Lianyungang City has increased but is still relatively low. Due to the late age of starting immunization, there are some differences in EV 71 vaccination among children with different residential attributes, residential regions, and gender, requiring targeted work.

Key words: Birth cohort, EV 71 vaccine, Vaccination, Vaccination rate

中图分类号:

R186

谢冰艳, 潘佑记, 陈玉格, 许雷. 连云港市2012—2021年出生队列儿童EV 71型疫苗接种情况分析[J]. 华南预防医学, 2023, 49(8): 981-985.

XIE Bingyan, PAN Youji, CHEN Yuge, XU Lei. Analysis of EV 71 vaccination status in Lianyungang City： a study from 2012-2021 birth cohort[J]. South China Journal of Preventive Medicine, 2023, 49(8): 981-985.

参考文献

[1] 李兰娟,任红.传染病学[M].北京:人民卫生出版社,2018:57-57.
[2] 刘向东,顾新蕊,冀天娇,等.2013—2015年中国重症手足口病的流行病学特征和病原构成[J].病毒学报,2018,34(4):477-482.
[3] 曹月,朱晶波.儿童手足口病重症病例神经系统损害表现及影响因素研究[J].华南预防医学,2021,47(10):1302-1304,1308.
[4] 高玉朋,马会会,赵跃媛.2009—2018年连云港市手足口病流行特征及病原学分析[J].现代预防医学,2020,47(11):1933-1936.
[5] 赵兴,李海朋,营亮,等.连云港市2013—2017年学校传染病流行病学特征[J].江苏预防医学,2020,31(1):65-66.
[6] 丁毅伟,韦欢欢,朱俊萍,等.中国手足口病血清流行病学研究进展[J].医学综述,2021,27(6):1074-1078,1083.
[7] 嵇红,鲍倡俊,祁贤,等.2009—2017年江苏省手足口病病原谱及柯萨奇A16型的分子流行病学研究[J].中国人兽共患病学报,2019,35(2):113-119.
[8] 中华人民共和国国家卫生健康委员会.手足口病诊疗指南(2018年版)[J].中华临床感染病杂志,2018,11(3): 161-166.
[9] Yang B,Liu F,Lao Q,et al.Epidlemiology of hand,foot and mouth diseuse in China,2008 to 2015 prior to the introduction of EV-A7l vaccine[J].Euro Surveill,2017,22(50):16-00824.
[10] 张静. 2008—2017年中国手足口病流行趋势和病原变化动态数列分析[J].中华流行病学杂志,2019,40(2):147-154.
[11] 钱素云,李兴旺.我国手足口病流行及诊治进展十年回首[J].中华儿科杂志,2018,56(5):321-323.
[12] Bello AM, Roshorm YM.Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD)[J].Biologicals,2022,79:1-9.
[13] Zhang X,Zhang Y,Li H,et al.Hand-foot-and-mouth disease-associated enterovirus and the development of multivalent HFMD vaccines[J].Int J Mol Sci,2022,24(1):169.
[14] 吴琳琳,刘捷宸,邵慧勇,等.上海市儿童肠道病毒71型灭活疫苗接种率和疑似预防接种异常反应监测[J].中国疫苗和免疫,2020,26(1):62-66,81.
[15] 于静,汤奋扬,汪志国,等.江苏省2013—2020年出生队列儿童肠道病毒71型疫苗接种率[J].中国疫苗和免疫,2021,27(5):566-569.
[16] 贾斯月,李靖欣,朱凤才.基于EV 71疫苗接种的江苏省手足口病动力学模型研究[J].中华疾病控制杂志,2019,23(3):253-258.
[17] 徐文婕,陈恩富.国产肠道病毒71型疫苗上市后免疫效果、安全性、接种意愿及其免疫策略研究进展[J].中华预防医学杂志,2020,54(9):1010-1016.
[18] 嵇红,张楠,霍翔,等.江苏省儿童家长肠道病毒71型灭活疫苗接种意愿和影响因素[J].中国疫苗和免疫,2020,26(1):76-81.
[19] 彭锐豪,曾路情,韦薇,等.我国儿童家长对EV 71疫苗知晓率与接受率的Meta分析[J].华南预防医学,2018,44(5):469-472.
[20] 于静,汤奋扬,汪志国,等.江苏省儿童预防接种门诊服务能力现况分析[J].现代预防医学,2018,45(21):3895-3898.
[21] 张芳,李玉.小儿二类疫苗接种现状调查及其相关影响因素分析[J].南昌大学学报(医学版),2019,59(1):79-82.